Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2525 of 3284 entries
View as:

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

Phase: N/A Priority: Normal
NCT ID: NCT00681395 Org: User:
Start: 05/31/08 End: - Due: -

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

Phase: N/A Priority: Normal
NCT ID: NCT06754761 Org: User:
Start: 01/17/25 End: 08/08/25 Due: 08/08/26

Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00729443 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

Phase: N/A Priority: Normal
NCT ID: NCT01104701 Org: User:
Start: 05/31/10 End: 12/31/10 Due: 12/31/11

A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00263276 Org: User:
Start: 12/31/05 End: 02/28/07 Due: 02/28/08

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04798222 Org: User:
Start: 06/29/21 End: 09/03/21 Due: 09/03/22

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

Phase: N/A Priority: Normal
NCT ID: NCT00652392 Org: User:
Start: 04/30/03 End: 06/30/04 Due: 06/30/05

AZD7268 Safety and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT01020799 Org: User:
Start: 11/30/09 End: 04/30/10 Due: 04/30/11

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00413686 Org: User:
Start: 12/31/06 End: 05/31/10 Due: 05/31/11

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06465485 Org: User:
Start: 02/28/24 End: 03/31/26 Due: 03/31/27

AZD9833 China PK Study

Phase: N/A Priority: Normal
NCT ID: NCT04818632 Org: User:
Start: 11/12/21 End: 09/07/23 Due: 09/07/24

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06344104 Org: User:
Start: 04/08/24 End: 05/20/26 Due: 05/20/27

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Phase: N/A Priority: Normal
NCT ID: NCT06494241 Org: User:
Start: 11/22/24 End: 11/28/27 Due: 11/28/28

A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03706690 Org: User:
Start: 11/27/18 End: 03/16/27 Due: 03/16/28

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00617669 Org: User:
Start: 01/31/08 End: 07/31/11 Due: 07/31/12

A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution

Phase: N/A Priority: Normal
NCT ID: NCT02446171 Org: User:
Start: 05/31/15 End: 07/31/15 Due: 07/31/16

PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

Phase: N/A Priority: Normal
NCT ID: NCT01020604 Org: User:
Start: 11/30/09 End: 03/31/13 Due: 03/31/14

Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

Phase: N/A Priority: Normal
NCT ID: NCT00254774 Org: User:
Start: 01/31/02 End: 03/31/06 Due: 03/31/07

D9319C00001- 1L OC Mono Global RCT

Phase: N/A Priority: Normal
NCT ID: NCT04884360 Org: User:
Start: 05/31/21 End: 04/30/26 Due: 04/30/27

Atlantis Symbicort

Phase: N/A Priority: Normal
NCT ID: NCT00646594 Org: User:
Start: 11/30/03 End: 01/31/05 Due: 01/31/06

Pharmacokinetic Study of Benralizumab in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03928262 Org: User:
Start: 04/02/19 End: 08/12/19 Due: 08/12/20

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03759288 Org: User:
Start: 12/07/18 End: 10/18/23 Due: 10/18/24

A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00055471 Org: User:
Start: 06/30/03 End: 10/31/05 Due: 10/31/06

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone

Phase: N/A Priority: Normal
NCT ID: NCT06388616 Org: User:
Start: 05/02/24 End: 09/05/24 Due: 09/05/25

General Practice Research Database Seroquel XR Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT01447082 Org: User:
Start: 10/31/08 End: 12/31/12 Due: 12/31/13